Pharmacokinetics and Pharmacodynamics Practice Questions

Q: Plasma concentrations (µg/mL) after intravenous administration of 5.1 mg/kg of Gentamicin to a hypothetical patient are depicted in the graph. Based on the concentration-time curve, what is the approximate elimination half-life of Gentamicin in this patient?

4 hours. The elimination half-life is the time required for the plasma concentration to fall by 50% during the terminal elimination phase. Reading from the graph, the plasma concentration falls from approximately 8 µg/mL at 4 hours to approximately 4 µg/mL at 8 hours — a halving over 4 hours. This pattern continues in subsequent intervals, confirming an elimination half-life of approximately 4 hours for Gentamicin in this patient.

Q: Which drug is highly distributed to body fat?

Thiopentone. ### Explanation The correct answer is **Thiopentone**. **1. Why Thiopentone is correct:** The distribution of a drug depends on its lipid solubility and ionization. Thiopentone is an ultra-short-acting barbiturate characterized by **extreme lipid solubility**. Upon intravenous administration, it rapidly crosses the blood-brain barrier to induce anesthesia. However, its action is terminated not by metabolism, but by **redistribution**. It moves from the highly vascular brain to less vascular but lipid-rich tissues like skeletal muscle and, eventually, **adipose tissue (body fat)**. Because fat has low blood flow, the drug accumulates there, acting as a reservoir. **2. Why the other options are incorrect:** * **Digoxin:** While it has a large volume of distribution ($V_d$), it primarily binds to **skeletal muscle** (via Na+/K+ ATPase) and heart tissue, not fat. * **Heparin:** This is a large, highly ionized (polar) molecule. It remains confined to the **plasma compartment** ($V_d \approx$ plasma volume) and does not distribute into tissues or fat. * **Mannitol:** It is a highly water-soluble (hydrophilic) sugar alcohol. It remains in the **extracellular fluid (ECF)** and does not cross cell membranes or distribute into adipose tissue. **3. NEET-PG High-Yield Pearls:** * **Redistribution:** This is the hallmark of highly lipid-soluble drugs (e.g., Thiopentone, Propofol). It explains why a patient wakes up quickly despite the drug still being present in the body. * **Volume of Distribution ($V_d$):** * Low $V_d$ (confined to plasma): Heparin, Warfarin. * Medium $V_d$ (ECF): Mannitol, Aminoglycosides. * High $V_d$ (Tissue binding): Digoxin, Chloroquine (highest $V_d$). * **Clinical Note:** In obese patients, Thiopentone can have a prolonged recovery time due to extensive accumulation in the large fat reservoir.

Q: Which of the following properties of a drug will enable it to be used in low concentration?

High affinity. **Explanation:** The correct answer is **High affinity**. **1. Why High Affinity is Correct:** Affinity refers to the chemical force that causes a drug to bind to its receptor. It is the measure of how tightly a drug binds to its target. In pharmacological terms, affinity is inversely proportional to the **Dissociation Constant ($K_d$)**. A drug with high affinity requires a very low concentration to occupy 50% of the available receptors. Therefore, drugs with high affinity can achieve their desired pharmacological effect even at low doses or concentrations. **2. Why Other Options are Incorrect:** * **High Specificity:** Specificity refers to the ability of a drug to act on a particular receptor type or tissue. While highly specific drugs have fewer side effects, specificity does not dictate the *amount* or *concentration* of the drug needed to trigger a response. * **Low Specificity:** This implies the drug binds to multiple receptor types (promiscuity), which usually leads to a higher incidence of adverse effects, but it does not determine the potency or concentration required for action. * **High Stability:** This relates to the drug's resistance to degradation (metabolism) and its shelf-life. While stability affects the duration of action and storage, it does not determine the concentration needed to initiate a receptor-mediated response. **3. NEET-PG High-Yield Pearls:** * **Potency vs. Efficacy:** Affinity is a major determinant of **Potency** (the amount of drug needed for an effect). **Efficacy** (Intrinsic Activity) is the ability of the drug to activate the receptor once bound. * **$K_d$ Relationship:** A lower $K_d$ value signifies higher affinity. * **Agonists vs. Antagonists:** Both agonists and antagonists possess affinity, but only agonists possess intrinsic activity (efficacy).

Q: Loading dose primarily depends on which pharmacokinetic parameter?

Volume of distribution. **Explanation:** The **Loading Dose (LD)** is the initial higher dose of a drug given at the beginning of a course of treatment before dropping to a lower maintenance dose. Its primary purpose is to rapidly achieve the **target therapeutic plasma concentration ($C_p$)**. **1. Why Volume of Distribution ($V_d$) is correct:** The loading dose is mathematically defined by the formula: $$\text{Loading Dose} = \frac{V_d \times \text{Target } C_p}{\text{Bioavailability (F)}}$$ Since the goal is to "fill up" the body's various compartments (tissues and plasma) to reach a specific concentration, the amount of drug required is directly proportional to the space it occupies ($V_d$). If a drug has a high $V_d$ (extensive tissue binding), a larger loading dose is needed. **2. Why the other options are incorrect:** * **Clearance (B):** This determines the **Maintenance Dose**. Clearance relates to how fast the drug is removed, which dictates how much must be replaced to maintain a steady state. * **Rate of administration (C):** This affects the peak plasma concentration and potential toxicity (especially with IV bolus) but does not determine the total dose required to reach steady state. * **Half-life (D):** This determines the **time taken** to reach steady state (usually 4–5 half-lives) and the dosing interval, but not the magnitude of the loading dose itself. **High-Yield Clinical Pearls for NEET-PG:** * **Loading Dose:** "Fills the tank" (Depends on $V_d$). * **Maintenance Dose:** "Replaces the leak" (Depends on Clearance). * **Clinical Example:** Digoxin and Phenytoin often require loading doses due to their large $V_d$ and the need for rapid effect. * **Note:** In patients with renal or hepatic failure, the loading dose usually remains the same (unless $V_d$ is altered), but the maintenance dose must be decreased.

Q: Which of the following medications inhibits the effect of oral contraceptive pills?

Rifampicin. **Explanation:** **1. Why Rifampicin is the Correct Answer:** Rifampicin is a potent **inducer of Cytochrome P450 (CYP450) enzymes**, specifically the CYP3A4 isoform. Oral contraceptive pills (OCPs) contain estrogen and progestin, which are metabolized by these liver enzymes. When Rifampicin induces these enzymes, it accelerates the metabolism and clearance of the hormones, leading to sub-therapeutic plasma levels. This results in **contraceptive failure** and breakthrough bleeding. It is the most notorious drug for this interaction. **2. Why the Other Options are Incorrect:** * **B. Cimetidine:** This is a potent **enzyme inhibitor**. It would typically increase the plasma levels of drugs metabolized by the liver, potentially increasing the side effects of OCPs rather than inhibiting their efficacy. * **C. Ethambutol:** Unlike Rifampicin, Ethambutol is an antitubercular drug that does not significantly affect the hepatic microsomal enzyme system. It has no documented interaction with OCPs. * **D. Propranolol:** This is a non-selective beta-blocker. While it is metabolized by the liver, it does not induce or inhibit enzymes in a way that would diminish the clinical effect of OCPs. **3. High-Yield Clinical Pearls for NEET-PG:** * **The "Inducer" Mnemonic:** Remember **GPRS Cell Phone** (Griseofulvin, Phenytoin, Rifampicin, Smoking, Carbamazepine, Phenobarbitone) as the classic CYP450 inducers. * **Patient Counseling:** Patients on OCPs starting Rifampicin therapy (e.g., for Tuberculosis) must be advised to use an **alternative/barrier method** of contraception. * **Broad Spectrum:** Rifampicin is a "pan-inducer," affecting almost all CYP families (1A2, 2C9, 2C19, 3A4).

Q: All of the following are examples of mechanism-based inhibition, EXCEPT?

Statins on HMG-CoA reductase. ### Explanation **Mechanism-based inhibition**, also known as **suicide inhibition** or irreversible covalent inhibition, occurs when an enzyme converts an initially inactive inhibitor (a "prodrug" or substrate analog) into a reactive intermediate. This intermediate then binds covalently and irreversibly to the enzyme's active site, permanently "killing" the enzyme. **Why Statins are the Correct Answer:** Statins (e.g., Atorvastatin) are **competitive, reversible inhibitors** of HMG-CoA reductase. They structurally resemble the natural substrate (HMG-CoA) and compete for the same binding site. Because the binding is non-covalent and reversible, they do not qualify as suicide inhibitors. **Analysis of Incorrect Options (Suicide Inhibitors):** * **Aspirin:** It irreversibly acetylates the serine residue at the active site of **Cyclooxygenase (COX-1 and COX-2)**. This is a classic example of covalent modification. * **Allopurinol:** It is converted by **Xanthine Oxidase** into its active metabolite, **Alloxanthine (Oxypurinol)**. Alloxanthine then binds tightly and irreversibly to the molybdenum ion in the enzyme's active site. * **Difluoromethylornithine (DFMO/Eflornithine):** It is a substrate analog that is activated by **Ornithine Decarboxylase**, leading to irreversible enzyme inactivation. It is used clinically for African Trypanosomiasis and hirsutism. **High-Yield NEET-PG Pearls:** * **Other Suicide Inhibitors:** Clavulanic acid (on $\beta$-lactamase), Selegiline (on MAO-B), Disulfiram (on Aldehyde dehydrogenase), and 5-Fluorouracil (on Thymidylate synthase). * **Key Distinction:** In competitive inhibition (Statins), $V_{max}$ remains unchanged while $K_m$ increases. In suicide inhibition, the enzyme is permanently inactivated, effectively decreasing the total enzyme concentration ($V_{max}$ decreases).

Question 1

Which of the following is characteristic of drugs exhibiting zero-order kinetics of elimination?

Accepted Answer

Their elimination half-life is independent of the dose.

Answer

They are more common than drugs following first-order kinetics.

Answer

Their concentration decreases exponentially with time.

Answer

A plot of drug concentration versus time is linear.

Question 2

Plasma concentrations (µg/mL) after intravenous administration of 5.1 mg/kg of Gentamicin to a hypothetical patient are depicted in the graph. Based on the concentration-time curve, what is the approximate elimination half-life of Gentamicin in this patient?

Accepted Answer

4 hours

Answer

8 hours

Answer

24 hours

Answer

12 hours

Answer

2 hours

Question 3

Which drug is highly distributed to body fat?

Accepted Answer

Thiopentone

Answer

Digoxin

Answer

Heparin

Answer

Mannitol

Question 4

Which of the following properties of a drug will enable it to be used in low concentration?

Accepted Answer

High affinity

Answer

High specificity

Answer

Low specificity

Answer

High stability

Question 5

Procainamide infusion is initiated. Its half-life is 2 hours. The infusion begins at 9:00 a.m. and ends at 1:00 p.m. on the same day. At 1:00 p.m., the blood concentration is found to be 3 mg/L. What is the probable steady-state concentration after 2 days of infusion?

Accepted Answer

4 mg/L

Answer

3 mg/L

Answer

6 mg/L

Answer

15 mg/L

Question 6

Loading dose primarily depends on which pharmacokinetic parameter?

Accepted Answer

Volume of distribution

Answer

Clearance

Answer

Rate of administration

Answer

Half-life

Question 7

Arrange the following drugs according to their half-life in increasing order: 1. Amiodarone 2. Adenosine 3. Esmolol 4. Omeprazole

Accepted Answer

2-3-4-1

Answer

1-2-4-3

Answer

2-3-1-4

Answer

4-3-1-2

Question 8

Which of the following medications inhibits the effect of oral contraceptive pills?

Accepted Answer

Rifampicin

Answer

Cimetidine

Answer

Ethambutol

Answer

Propranolol

Question 9

A 500-mg dose of a drug has therapeutic efficacy for 6 hours. If the half-life of the drug is 8 hours, for how long would a 1-gm dose be effective?

Accepted Answer

14 hours

Answer

12 hours

Answer

16 hours

Answer

24 hours

Question 10

All of the following are examples of mechanism-based inhibition, EXCEPT?

Accepted Answer

Statins on HMG-CoA reductase

Answer

Aspirin on cyclooxygenase

Answer

Allopurinol on Xanthine oxidase

Answer

Difluoromethylornithine on ornithine decarboxylase

Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics — MCQs

On this page

Practice by Chapter

Want unlimited practice?